LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$91.41 USD
+1.45 (1.61%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $91.37 -0.04 (-0.04%) 7:16 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
LMAT 91.41 +1.45(1.61%)
Will LMAT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LMAT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LMAT
All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy
Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?
LMAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why
Here's Why Universal Health Shares are Attracting Investors Now
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
Other News for LMAT
BCE Is Dead To Me - August Dividend Income Report
Conestoga Capital Advisors Q2 2024 Commentary
LeMaitre to Participate at Upcoming Investor Conferences in September
Lemaitre Vascular (LMAT) Gets a Buy from Lake Street
LeMaitre Vascular CFO Retires, Joins Board of Directors